Raleigh, N.C. | January 28, 2026 — Lumexa Imaging, one of the largest U.S. providers of outpatient diagnostic imaging services, announced that Jennifer L. Kemp, MD, Chair of Lumexa Imaging’s Center for Quality, has been elected to the Board of Directors of the Radiological Society of North America (RSNA). Dr. Kemp will also serve as the RSNA board liaison for government relations, positioning her to influence national priorities in radiology quality, patient-centered care, and healthcare policy at a time of rapid technological and regulatory change.
Science Significance
From a scientific and clinical perspective, Dr. Kemp’s election highlights the growing emphasis on quality science in diagnostic imaging, where accuracy, standardization, and clinical relevance directly affect patient outcomes. RSNA plays a central role in advancing evidence-based imaging practices, education, and research standards across radiology subspecialties. Dr. Kemp’s leadership background in imaging quality systems and patient experience supports the integration of clinical rigor with emerging innovations, including AI-enabled radiology tools designed to enhance interpretation, reporting clarity, and diagnostic consistency across large imaging networks.
Regulatory Significance
The appointment carries notable regulatory and cGxP-adjacent significance, particularly as radiology intersects with clinical trials, diagnostic endpoints, and regulated healthcare delivery. As RSNA’s liaison for government relations, Dr. Kemp will help shape dialogue between radiology professionals and policymakers on issues such as quality standards, technology oversight, data transparency, and patient safety. Diagnostic imaging is increasingly scrutinized within GCP-aligned clinical research and real-world evidence generation, making leadership that understands compliance, governance, and quality frameworks essential to maintaining trust and regulatory alignment.
Business Significance
Advertisement
For Lumexa Imaging, the election reinforces its positioning as a national leader in imaging quality and operational excellence. With more than 185 outpatient imaging centers across 13 states and millions of scans performed annually, Lumexa operates at a scale where standardized quality governance and innovation adoption are critical competitive differentiators. Dr. Kemp’s role on the RSNA Board enhances Lumexa’s visibility and influence within the radiology ecosystem, supporting strategic engagement with health systems, technology partners, and regulators as the imaging market evolves alongside AI-driven diagnostics and value-based care models.
Patients’ Significance
For patients, Dr. Kemp’s leadership aligns directly with improved access to understandable, patient-centered imaging information. In addition to her Lumexa role, she serves as Chief of Patient Experience at Scanslated, an AI-driven platform used by Lumexa to translate complex radiology reports into clear, patient-friendly language. More than 2 million patient reports have been accessed through the platform, with survey data showing strong patient preference and satisfaction. This focus on health literacy and transparency supports better patient engagement, informed decision-making, and trust in diagnostic care.
Policy Significance
At the policy level, Dr. Kemp’s election comes at a pivotal moment for radiology as stakeholders address AI governance, reimbursement reform, workforce challenges, and patient access. RSNA serves as a key voice in shaping national imaging policy and advocacy, and Dr. Kemp’s dual focus on quality and patient experience aligns with broader healthcare goals of equity, safety, and value-based outcomes. Her role strengthens collaboration between professional societies, healthcare providers, and government bodies as radiology adapts to evolving technology, data, and regulatory landscapes.
Overall, Dr. Jennifer L. Kemp’s election to the RSNA Board of Directors underscores the increasing importance of quality-driven leadership in medical imaging. By bridging clinical excellence, patient-centered innovation, and policy engagement, her appointment reflects how modern radiology leadership extends beyond the reading room into national governance and healthcare transformation. For the cGxP.wire audience, the announcement highlights the expanding role of MedTech quality systems, compliance-aware innovation, and patient-focused design in shaping the future of diagnostic medicine.
Source: Lumexa Imaging press release
